PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding PAVmed Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 32 | −3 |
| Shares | 1.61M | 67 | 2.11M | +496.4K (+30.8%) |
| Value | $677.4K | $29 | $468.8K | −$208.6K (−30.8%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held PAVmed Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 68,210 | $15.1K | 0.00% |
| Gsa Capital Partners LLP | 65,903 | $15.0K | 0.00% |
| StoneX Group Inc. | 12,303 | $2.72K | 0.00% |
Sold out (6)
Institutions that held PAVmed Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Jane Street Group, LLC | 152,304 | $65.6K |
| Virtu Financial LLC | 38,974 | $17.0K |
| Obermeyer Wood Investment Counsel, LLLP | 21,500 | $9.27K |
| Barclays PLC | 69 | $29 |
| Citigroup Inc | 38 | $16 |
| Summit Wealth Group LLC | 43,017 | – |
Not filed for Q4 2025 yet (1)
Institutions that held PAVmed Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Binnacle Investments Inc | 67 | $29 |